Literature DB >> 32405722

TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitment.

Bertille Montibus1,2, Jil Cercy1, Tristan Bouschet3, Amandine Charras1,4, Stéphanie Maupetit-Méhouas1, David Nury1, Céline Gonthier-Guéret1, Sabine Chauveau1, Nicolas Allegre1, Caroline Chariau5, Charles C Hong6, Isabelle Vaillant1, C Joana Marques7,8,9,10, Franck Court11, Philippe Arnaud12.   

Abstract

The acquisition of cell identity is associated with developmentally regulated changes in the cellular histone methylation signatures. For instance, commitment to neural differentiation relies on the tightly controlled gain or loss of H3K27me3, a hallmark of polycomb-mediated transcriptional gene silencing, at specific gene sets. The KDM6B demethylase, which removes H3K27me3 marks at defined promoters and enhancers, is a key factor in neurogenesis. Therefore, to better understand the epigenetic regulation of neural fate acquisition, it is important to determine how Kdm6b expression is regulated. Here, we investigated the molecular mechanisms involved in the induction of Kdm6b expression upon neural commitment of mouse embryonic stem cells. We found that the increase in Kdm6b expression is linked to a rearrangement between two 3D configurations defined by the promoter contact with two different regions in the Kdm6b locus. This is associated with changes in 5-hydroxymethylcytosine (5hmC) levels at these two regions, and requires a functional ten-eleven-translocation (TET) 3 protein. Altogether, our data support a model whereby Kdm6b induction upon neural commitment relies on an intronic enhancer the activity of which is defined by its TET3-mediated 5-hmC level. This original observation reveals an unexpected interplay between the 5-hmC and H3K27me3 pathways during neural lineage commitment in mammals. It also questions to which extent KDM6B-mediated changes in H3K27me3 level account for the TET-mediated effects on gene expression.

Entities:  

Keywords:  5-Hydroxymethylcytosine; Enhancer; H3K27me3; Kdm6b; Neural stem cells; Neurogenesis; Tet3

Year:  2020        PMID: 32405722     DOI: 10.1007/s00018-020-03541-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  41 in total

1.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

Review 2.  A double take on bivalent promoters.

Authors:  Philipp Voigt; Wee-Wei Tee; Danny Reinberg
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

3.  Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage.

Authors:  Wen-Hui Lien; Xingyi Guo; Lisa Polak; Lee N Lawton; Richard A Young; Deyou Zheng; Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2011-09-02       Impact factor: 24.633

4.  Epigenome profiling and editing of neocortical progenitor cells during development.

Authors:  Mareike Albert; Nereo Kalebic; Marta Florio; Naharajan Lakshmanaperumal; Christiane Haffner; Holger Brandl; Ian Henry; Wieland B Huttner
Journal:  EMBO J       Date:  2017-08-01       Impact factor: 11.598

5.  Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex.

Authors:  João D Pereira; Stephen N Sansom; James Smith; Marc-Werner Dobenecker; Alexander Tarakhovsky; Frederick J Livesey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 6.  PRC2 mediated H3K27 methylations in cellular identity and cancer.

Authors:  Eric Conway; Evan Healy; Adrian P Bracken
Journal:  Curr Opin Cell Biol       Date:  2015-11-11       Impact factor: 8.382

7.  Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors.

Authors:  Fabio Mohn; Michael Weber; Michael Rebhan; Tim C Roloff; Jens Richter; Michael B Stadler; Miriam Bibel; Dirk Schübeler
Journal:  Mol Cell       Date:  2008-05-29       Impact factor: 17.970

8.  Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.

Authors:  Kairong Cui; Chongzhi Zang; Tae-Young Roh; Dustin E Schones; Richard W Childs; Weiqun Peng; Keji Zhao
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

9.  A mono-allelic bivalent chromatin domain controls tissue-specific imprinting at Grb10.

Authors:  Lionel A Sanz; Stormy Chamberlain; Jean-Charles Sabourin; Amandine Henckel; Terry Magnuson; Jean-Philippe Hugnot; Robert Feil; Philippe Arnaud
Journal:  EMBO J       Date:  2008-07-24       Impact factor: 11.598

10.  Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive.

Authors:  Stéphanie Maupetit-Méhouas; Bertille Montibus; David Nury; Chiharu Tayama; Michel Wassef; Satya K Kota; Anne Fogli; Fabiana Cerqueira Campos; Kenichiro Hata; Robert Feil; Raphael Margueron; Kazuhiko Nakabayashi; Franck Court; Philippe Arnaud
Journal:  Nucleic Acids Res       Date:  2015-09-22       Impact factor: 16.971

View more
  3 in total

1.  The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation.

Authors:  Elisa Le Boiteux; Pierre-Olivier Guichet; Konstantin Masliantsev; Bertille Montibus; Catherine Vaurs-Barriere; Céline Gonthier-Gueret; Emmanuel Chautard; Pierre Verrelle; Lucie Karayan-Tapon; Anne Fogli; Franck Court; Philippe Arnaud
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

Review 2.  Intragenic CpG Islands and Their Impact on Gene Regulation.

Authors:  James A Cain; Bertille Montibus; Rebecca J Oakey
Journal:  Front Cell Dev Biol       Date:  2022-02-11

Review 3.  TET Enzymes and 5-Hydroxymethylcytosine in Neural Progenitor Cell Biology and Neurodevelopment.

Authors:  Ian C MacArthur; Meelad M Dawlaty
Journal:  Front Cell Dev Biol       Date:  2021-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.